Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells

Cytotechnology

Volumn 26, Issue 2, 1998, Pages 119-124

  Horiuchi, Ken Ichi ^a   Tsurushima, Hideo ^a,b   Kim, Berm Soo ^a   Liu, Shu Qin ^a   Saijo, Kaoru ^a   Saijo, Yasuo ^c   Nukiwa, Toshihiro ^c   Nomura, Nakao ^a   Matsumura, Masatoshi ^a   Ohno, Tadao ^a,d  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Adoptive immunotherapy; Cytotoxic T lymphocyte; Formalin fixed tumor cell

Indexed keywords

EID: 6844237663     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007903614475     Document Type: Article

References (12)

1. Crowley NJ, Darrow TL, Quinn-Allen MA and Seigler HF (1991) MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol 146: 1692-1699.
2. David P, Zemin W, Caroly D, Hongzhen H, David M, Guimin G, Yunsheng W, Theresa W, Jeffrey B, James L and Patritia WF (1996) Regulation of CTLA-4 expression during T cell activation. J Immunol 156: 4154-4159.
3. Hay RJ, Park J-G and Gazar A (Edited) (1994) Atlas of human tumor cell lines. Academic Press, Inc., CA, USA.
4. Holden CA, Spaull J, Williams R, Spry CJF, Jones RR and Jones EW (1986) The detection of endothelial cell antigens in cutaneous tissue using methacarn and periodate lysine paraformaldehyde fixation. J Immunol Methods 91: 45-52.
5. Kawai K, Sasaki T, Saijo-Kurita K, Akaza H, Koiso K and Ohno T (1992) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determinded by lactate-dehydrogenase-release assay. Cancer Immunol Immunother 35: 225-229.
6. Liu SQ, Saijo K, Todoroki T and Ohno T (1995) Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nature Med 1: 267-271.
7. Liu SQ, Shiraiwa H, Kawai K, Hayashi H, Akaza H, Kim BS, Oki A, Nishida M, Kubo T, Hashizaki K, Saijo K and Ohno T (1996) Tumor-specific autologous cytotoxic T lymphocytes from tissue sections. Nature Med 2: 1283-1283.
8. Muul LM, Speiess PJ, Drector EP and Rosenberg SA (1987) Identification of specific cytolytic immuno response against autologous tumor in humans bearing malignant melanoma. J Immunol 138: 989-995.
9. Pollard K and Holgate CS (1987) Surface antigen preservation by PLP and formalin fixation and the effects of tissue processing. J Immunol Methods 96, 145-145.
10. Schwartz RH (1992) Costimulation of T lymphocytes the role of CD28, CTLA-4, and B-7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068.
11. Tjoa BA and Kranz DM (1994) Generation of cytotoxic T-lymphocyte to self-peptide/class I complex: a mode for peptide-mediated tumor rejection. Cancer Res 54: 204-208.
12. Wolfel T, Herr W, Coulie P, Schmitt U, Meyer zum Buschenfelde KH and Knuth A (1993) Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones. Int J Cancer 54: 636-644.